Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Saudi Chemical CoSAU:2230 -3.98%85 EV-to-EBIT is 15.08 as of Sep. 16, 2026, which is 30% below its 10-year median of 21.50. GuruFocus rates SAU:2230 with a GF Score™ of 85/100 and a GF Value™ of ﷼8.72 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 682 Drug Manufacturers companies, Saudi Chemical Co ranks better than 51.91% on this metric.
Saudi Chemical Co (SAU:2230) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Saudi Chemical Co's Enterprise Value for the quarter that ended in Jun. 2026 was ﷼7,908 Mil.
Saudi Chemical Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼485 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saudi Chemical Co EV-to-EBIT Related Terms
Saudi Chemical Co EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Saudi Chemical Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAU:2230 vs ZTS, UTHR, VTRS: EV-to-EBIT Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Saudi Chemical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Saudi Chemical Co EV-to-EBIT vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Saudi Chemical Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Saudi Chemical Co's EV-to-EBIT falls into.
Saudi Chemical Co's current Enterprise Value is ﷼7,318 Mil.
Saudi Chemical Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼485 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saudi Chemical Co (SAU:2230) has a EV-to-EBIT of 15.08 as of Sep. 16, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Saudi Chemical Co and its competitors. This is 30% below median its historical median of 21.50. According to the industry distribution chart, Saudi Chemical Co ranks #328 out of 682 companies in the Drug Manufacturers industry, placing it in the top 48.1%.
Is Saudi Chemical Co's EV-to-EBIT too high?
Saudi Chemical Co's current EV-to-EBIT of 15.08 is 30% below median its 10-year median of 21.50. The Drug Manufacturers industry median EV-to-EBIT is 16.04. Saudi Chemical Co's value of 15.08 is 6% below this industry median. Based on the distribution chart, Saudi Chemical Co ranks #328 out of 682 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Saudi Chemical Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Saudi Chemical Co's EV-to-EBIT compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Saudi Chemical Co ranks #328 out of 682 companies for EV-to-EBIT. This puts Saudi Chemical Co in the upper half of its industry. The industry median EV-to-EBIT is 16.04. Saudi Chemical Co's value of 15.08 is 6% below this benchmark. While the company's 10-year median is 21.50 vs. the industry median of 16.04, Saudi Chemical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Drug Manufacturers company?
The median EV-to-EBIT among Drug Manufacturers companies is 16.04, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Saudi Chemical Co's current EV-to-EBIT of 15.08 is 6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Saudi Chemical Co and its competitors. For the Drug Manufacturers industry, the median EV-to-EBIT is 16.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Saudi Chemical Co's current EV-to-EBIT is 15.08, which is 30% below median its own 10-year median of 21.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saudi Chemical Co stock overvalued right now?
Based on GuruFocus' analysis, Saudi Chemical Co (SAU:2230) is currently considered Modestly Undervalued. The stock's GF Value™ is ﷼8.72, compared to a current price of ﷼7.53 — trading 13.6% below its estimated fair value. The current EV-to-EBIT is 15.08, which is 30% below median its 10-year median of 21.50 and 6% below the Drug Manufacturers industry median of 16.04. Saudi Chemical Co's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Saudi Chemical Co (SAU:2230), the current EV-to-EBIT is 15.08 as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Saudi Chemical Co (SAU:2230) Overvalued in 2026?
Based on GuruFocus' analysis, Saudi Chemical Co stock appears to be undervalued.
The current stock price of ﷼7.53 is trading 13.6% below its estimated GF Value™ of ﷼8.72.
GuruFocus considers Saudi Chemical Co to be Modestly Undervalued.
Key valuation signals for SAU:2230:
EV-to-EBIT: 15.08 (30% below median its 10-year median of 21.50)
GF Value™: ﷼8.72 vs. price of ﷼7.53 (13.6% below fair value)
Industry Position: 6% below the Drug Manufacturers median (#328 of 682)
No single metric tells the full story. See the SAU:2230 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Saudi Chemical Co, along with its subsidiaries, is engaged in the manufacturing and distribution of explosives and their derivatives. Its other business operations include providing technical support services in explosions, wholesale and retail trading in medicines, medical materials and syrups, pharmaceutical preparations, medical and surgical tools, and equipment, supplies of hospitals and medical centers, and the manufacture of ammonium nitrate. The company operates in three segments: Explosives, Medicines & medical supplies, and Production of Ammonium Nitrate. It generates the majority of its revenue from Medicines & medical supplies.
85GF Score
Get the complete analysis for SAU:2230
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:2230 has been successfully added to your 
